State Street Corporation Common Stock vs 22nd Century Group Inc — how do they compare? State Street Corporation Common Stock trades at $174.96 (market cap $48.10B), while 22nd Century Group Inc trades at $0.81 (market cap $621.67K). The key difference: State Street Corporation Common Stock is far larger — about 77372.2× 22nd Century Group Inc's market cap, and State Street Corporation Common Stock pays a 2.1% dividend while 22nd Century Group Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold State Street Corporation Common Stock for 1 Days and 22nd Century Group Inc for 32 Days on average.
| STT | XXII | |
|---|---|---|
Market Cap | $48.10B | $621.67K |
Volume | 2,033,865 | 45,625 |
Sector | Financials | Consumer Staples |
52-Week High | $194.26 | $483.00 |
52-Week Low | $111.00 | $0.80 |
Typical Hold Time | 1 Days | 32 Days |
Enterprise Value | $74.64B | -$3.69M |
Dividend Yield | 2.1% | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
XXII trades at $0.8116, down 8.96% in the last session, with a bearish technical signal from moving averages. The company shows negative profitability metrics including -76.01% net income margin and -284.5% ROE, though valuation ratios appear low with P/S of 0.08 and P/B of 0.03. Recent news highlights regulatory progress in reduced-nicotine tobacco initiatives in France and Europe.
While analyst consensus is 75% buy with a $1,240 price target suggesting significant upside, fundamental challenges persist with consecutive earnings misses and negative cash flow from operations. The stock faces execution risk in commercializing its reduced-nicotine platform amid ongoing losses.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
State Street provides investment servicing, custody, and asset management services to institutional investors. Its asset management business includes the SPDR ETF range.
Read more on STT →22nd Century Group is a plant biotechnology company that uses genetic engineering and gene editing to control the levels of nicotine in tobacco plants. Its flagship product line, VLN®, is the first and only combustible cigarette authorized by the FDA as a Modified Risk Tobacco Product (MRTP), containing 95% less nicotine than traditional cigarettes to help adult smokers smoke less.
Read more on XXII →